Covered recipient · General Payments record
DEEPTI M WARAD
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2019–2020
$43,890.91
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Grant | $39,868.95 | 10 |
| Consulting Fee | $967.50 | 1 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $39,868.95 | 10 |
| Bayer HealthCare Pharmaceuticals Inc. | $967.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $967.50 | 12/01/2020 | Consulting Fee | Undisputed | 01/23/2026 | 713634305 | CMS |
| Novo Nordisk Inc | $1,168.31 | 01/31/2020 | Grant | Undisputed | 01/23/2026 | 745064917 | CMS |
| Novo Nordisk Inc | $5,111.44 | 02/29/2020 | Grant | Undisputed | 01/23/2026 | 745064921 | CMS |
| Novo Nordisk Inc | $2,044.58 | 03/31/2020 | Grant | Undisputed | 01/23/2026 | 745064925 | CMS |
| Novo Nordisk Inc | $4,235.18 | 04/30/2020 | Grant | Undisputed | 01/23/2026 | 745064927 | CMS |
| Novo Nordisk Inc | $788.58 | 05/31/2020 | Grant | Undisputed | 01/23/2026 | 745064931 | CMS |
| Novo Nordisk Inc | $2,628.56 | 06/30/2020 | Grant | Undisputed | 01/23/2026 | 745064933 | CMS |
| Novo Nordisk Inc | $4,322.81 | 07/31/2020 | Grant | Undisputed | 01/23/2026 | 745064937 | CMS |
| Novo Nordisk Inc | $292.07 | 08/31/2020 | Grant | Undisputed | 01/23/2026 | 745064941 | CMS |
| Novo Nordisk Inc | $4,965.40 | 09/30/2020 | Grant | Undisputed | 01/23/2026 | 745064943 | CMS |
| Novo Nordisk Inc | $14,312.02 | 11/30/2020 | Grant | Undisputed | 01/23/2026 | 745064947 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020
- Source files
- Dataset page · Bulk file · PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.